Carl Icahn No Longer Holds Stake in Genzyme (GENZ)
More News related to GENZ
- David Moenning’s Daily State of the Markets: 6/26
- Goldman Sachs Lowers Price Target On Genzyme (GENZ); Maintains Sell
- Genzyme Reports Progress Related to Allston Plant
- RBC Capital Initiates Coverage on Genzyme (GENZ) with an Outperform
- Baird Is a Buyer of BioMarin (BMRN) On Genzyme-Related Weakness
Carl Icahn no longer holds a stake in Genzyme (Nasdaq: GENZ), according to his fund's 13F for quarter ended 12/31/07. Icahn held 1,518,463 shares at the quarter ended 9/30/07.
Related Categories
Insider TradesStocks Mentioned
-0.67Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
